Page last updated: 2024-10-30

metformin and Chagas Cardiomyopathy

metformin has been researched along with Chagas Cardiomyopathy in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Chagas Cardiomyopathy: A disease of the CARDIAC MUSCLE developed subsequent to the initial protozoan infection by TRYPANOSOMA CRUZI. After infection, less than 10% develop acute illness such as MYOCARDITIS (mostly in children). The disease then enters a latent phase without clinical symptoms until about 20 years later. Myocardial symptoms of advanced CHAGAS DISEASE include conduction defects (HEART BLOCK) and CARDIOMEGALY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vilar-Pereira, G1
Carneiro, VC1
Mata-Santos, H1
Vicentino, AR1
Ramos, IP1
Giarola, NL1
Feijó, DF1
Meyer-Fernandes, JR1
Paula-Neto, HA1
Medei, E1
Bozza, MT1
Lannes-Vieira, J1
Paiva, CN1

Other Studies

1 other study available for metformin and Chagas Cardiomyopathy

ArticleYear
Resveratrol Reverses Functional Chagas Heart Disease in Mice.
    PLoS pathogens, 2016, Volume: 12, Issue:10

    Topics: Animals; Antioxidants; Chagas Cardiomyopathy; Cyclic N-Oxides; Disease Models, Animal; Female; Male;

2016